BRAF gene test kits

1.Multiple myeloma diagnosis and treatment guidelines suggest that FISH detection sites include: IGH translocation, 17p- (P53 deletion), 13q14 deletion, 1q21 amplification. If FISH detects positive IGH translocation, then further testing ...

... . To judge breast cancer prognosis: HER2 gene amplification patient prognosis difference, disease-free survival and total survival significantly shortened. 3. Breast cancer endocrine treatment Guide: HER2 gene ...

1. TOP2A gene amplification is often accompanied by HER-2 gene amplification in patients (about 30%-50%), which accounts for 8% of all breast cancers and has a poor prognosis. 2. CEF regimen can reduce ...

1. ZNF217 gene was amplified in breast cancer, and its status was related to tumor invasion. 2. ZNF217 gene was also amplified in other tumors such as ovarian/colorectal/head and neck/pancreatic cancer, ...

1. C-myc gene can be amplified in a variety of tumors, such as breast cancer and cervical cancer, with poor prognosis. 2. To detect polyploid of chromosome 8.

... than 5% of the cell color), after then do FISH to confirm positive.ALK gene fusion is an important biological characteristic of non-small cell lung cancer. Patients with positive ALK gene fusion are sensitive ...

... inhibitor (TKIs) was significantly improved in patients with EGFR gene amplification (80% of lung cancer). 2.The utilization of screening of NSCLC patients for TKIs treatment 3. EGFR gene amplification ...

1. In non-small cell lung cancer, inv (2) (P21; P23) forms a molecular subunit of the fusion gene EML4-ALK, which is the target of the targeted drug Crizotinib. 2. A new EML4-ALK evaluation item was added to the 2010 ...

... cell lung cancer, C-MET gene amplification was closely associated with poor prognosis and EGFR-TKIS resistance (seen in 11-22% of cases). 3.C-MET gene amplification is one of the targets of Crizotinib. ...

1.ROS1 gene is expressed in brain, lung, gastric, breast and liver tumors, and translocated with other genes in non-small cell lung cancer cells (for example, SCL34A2, CD74, etc.). 2. The proportion ...

Result display time: 4 h

... is malignant neoplasm driven by various of tumorigenesis factors. Gene mutations caused by environment and heredity (including point mutation, deletion, insertion, copy number gain, gene fusion and so ...